(Q38088013)

28 August 2017

title

Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome (English)

1 reference

non-small-cell lung carcinoma

28 August 2017

1 reference

1 reference

Ya-Wen Zheng

1

1 reference

28 August 2017

Run-Mei Li

series ordinal

2

1 reference

28 August 2017

Xin-Wei Zhang

series ordinal

3

1 reference

28 August 2017

Xiu-Bao Ren

series ordinal

4

1 reference

28 August 2017

publication date

1 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

31

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

197-205

1 reference

Problems involved in the clinical trials for non-small cell lung carcinoma

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

T cell-based immunotherapy for cancer: a virtual reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Targeted therapies for advanced non-small-cell lung cancer: current status and future implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Ipilimumab: its potential in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Current vaccine updates for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Cytokine-induced NK-like T cells: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Gammadelta T cells and the lymphoid stress-surveillance response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

γδ T-cell immunotherapy for lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Granzyme B-mRNA expression by equine lymphokine activated killer (LAK) cells is associated with the induction of apoptosis in target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Cell transfer regimens in patients with highly advanced surgically unresectable non-small cell lung cancer: significantly improved overall survival in patients with lower levels of serum immunosuppressive acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Antitumor activity of cytokine-induced killer cells against human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Monitoring cytokine profiles during immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

New adoptive immunotherapy strategies for solid tumours with CIK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Review of Chinese clinical trials on CIK cell treatment for malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Lung cancer: New biological insights and recent therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

Defining the critical hurdles in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.775294

10.3109/07357907.2013.775294

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference